An American Sickness: How Healthcare Became Big Business and How You Can Take It Back

by Elisabeth Rosenthal

the FDA yardstick for approval did not include any consideration of price or measure of cost-effectiveness—a metric that virtually all other countries now use as they consider admitting new drugs to their formulary.